現(xiàn)貨供應，歡迎訂購！

Pall Ultroser G serum substitute 血清替代品 產(chǎn)品介紹：
Ultroser™ G血清替代品可以在細胞培養(yǎng)基中成功替代FCS（胎牛血清）。Ultroser™ G血清替代品設計用于依賴貼壁細胞的體外培養(yǎng)。已在羊膜液細胞原代培養(yǎng)中測試過，旨在確認其核型分析能力。Ultroser G血清替代品通過CE標記注冊。
Ultroser G血清替代品通過一系列質(zhì)量測試，包括PH、蛋白質(zhì)濃度、無菌控制、細菌和真菌、牛病毒（BHV1-DVB/MM,紅細胞吸附）、支原體、Hep G2細胞增殖能力、核型分析等。

Pall Ultroser G serum substitute 血清替代品 產(chǎn)品特性：
? 半固定成份確保批次間可重現(xiàn)性
? 低蛋白含量
? 方便使用和保藏
? Ultroser G血清替代品濃度是胎牛血清濃度的5倍（2%血清替代品相當于10%胎牛血清）

 英文簡述：
Ultroser™ G serum substitute can successfully replace FCS （fetal calf serum） in cell culture medium. It is designed for the in vitro culture of anchorage-dependent cells. It is specially tested as the primary culture from amniotic liquid cells and is designed to confirm their ability for karyotyping. Ultroser G serum substitute is CE mark-certified.
Ultroser G serum substitute has a concentration five times higher than fetal calf serum （2 % of reconstituted Ultroser G serum substitute is equivalent to 10%  fetal calf serum in the basal medium）.

Quality Control Tests
Tests usually performed on Ultroser G serum substitute are:
● Physicochemical parameters pH
● Protein concentration
● Sterility control
● Bacteria & Fungi
● Bovine viruses （BHV1-DVB/MM, hemadsorbents）
● Proliferation capacity on Hep G2
● Mycoplasma
● Karyotyping

重慶市華雅干細胞技術(shù)有限公司